Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ANGIOTENSIN AMIDE
ID: ALA409803
Max Phase: Phase
Molecular Formula: C49H70N14O11
Molecular Weight: 1031.19
Molecule Type: Protein
Associated Items:
ID: ALA409803
Max Phase: Phase
Molecular Formula: C49H70N14O11
Molecular Weight: 1031.19
Molecule Type: Protein
Associated Items:
Synonyms (2): Asn-arg-val-tyr-val-his-pro-phe | NSC-107678
Synonyms from Alternative Forms(2):
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
Standard InChI: InChI=1S/C49H70N14O11/c1-26(2)39(61-42(67)33(12-8-18-55-49(52)53)57-41(66)32(50)23-38(51)65)45(70)58-34(20-29-14-16-31(64)17-15-29)43(68)62-40(27(3)4)46(71)59-35(22-30-24-54-25-56-30)47(72)63-19-9-13-37(63)44(69)60-36(48(73)74)21-28-10-6-5-7-11-28/h5-7,10-11,14-17,24-27,32-37,39-40,64H,8-9,12-13,18-23,50H2,1-4H3,(H2,51,65)(H,54,56)(H,57,66)(H,58,70)(H,59,71)(H,60,69)(H,61,67)(H,62,68)(H,73,74)(H4,52,53,55)/t32-,33-,34-,35-,36-,37-,39-,40-/m0/s1
Standard InChI Key: JYPVVOOBQVVUQV-CGHBYZBKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1031.19 | Molecular Weight (Monoisotopic): 1030.5348 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hsieh KH, Marshall GR.. (1986) Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II., 29 (10): [PMID:3761315] [10.1021/jm00160a028] |
2. Samanen J, Narindray D, Cash T, Brandeis E, Adams W, Yellin T, Eggleston D, DeBrosse C, Regoli D.. (1989) Potent angiotensin II antagonists with non-beta-branched amino acids in position 5., 32 (2): [PMID:2913307] [10.1021/jm00122a030] |
3. Hsieh KH, LaHann TR, Speth RC.. (1989) Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8., 32 (4): [PMID:2704034] [10.1021/jm00124a028] |
4. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
5. Hsieh K, Jorgensen EC, Lee TC.. (1979) Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity., 22 (9): [PMID:490548] [10.1021/jm00195a005] |
6. Galardy RE, Stafford SS, Schaefer ML, Ho H, La Vorgna KA, Jamieson JD.. (1978) Biologically active derivatives of angiotensin for labeling cellular receptors., 21 (12): [PMID:214560] [10.1021/jm00210a020] |
7. WHO Anatomical Therapeutic Chemical Classification, |
Source(3):